GRAIL President Discusses Gaps and Opportunities in Cancer Care

Despite advances in cancer care, critical gaps remain, and many cancers still go undetected until it's too late. Hear Josh Ofman, MD, MSHS, President of GRAIL, explain how the Galleri multi-cancer early detection (MCED) test can detect more than 50 types of cancer before symptoms appear[1] – when there may be more treatment options available.[2,3] Learn more: http://galleri.com http://grail.com Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers, and not all cancers can be detected in the blood. False-positive and false-negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Rx only. See Important Safety Information: https://www.galleri.com/safety-information 1. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021;32(9):1167-1177. doi:10.1016/j.annonc.2021.05.806 2. American Cancer Society. The cancer atlas. [Internet] Early detection. https://canceratlas.cancer.org/taking-action/early-detection/ 3. Etzioni R, Urban N, Ramsey S, et al. The case for early detection. Nat Rev Cancer. 2003 Apr;3(4):243-52. doi: 10.1038/nrc1041